What is Most Important When Conducting Oncology Clinical Research in Canada?
Developing oncology compounds is a constantly evolving process, and with the dramatic rise in costs, and competitive trials, making every…
Daffodils & Cancer Research – what’s the connection?
The daffodil is a symbol of strength, of resilience, of courage and life. It survives our harsh Canadian winters to…
What to Look for When Selecting a CRO – Real World Evidence
There is a myriad of factors involved in selecting a CRO. Do CRO team members have the necessary therapeutic expertise?…
2018 in Retrospect – Real World Evidence of Win-Win CRO/Sponsor Relationships
What’s in Store for 2019 and Beyond? The Clinical Trials Market was valued at USD 32,700 million in 2017 and…
Real World Evidence of a Successful Oncology Trial Rescue in Canada
Each clinical study presents unique challenges, and it’s not unusual despite every effort that a clinical trial does not proceed…
How Does Your CRO’s Feasibility Process Contribute to Your Clinical Trial Success?
In clinical research, the process of finding and selecting sites is essential to the success of a study, as it…
Canadian Know-How: Successfully Navigating a Centralized Framework for Oncology Clinical Trial Ethical Review
Now more than ever, time is of the essence when it comes to oncology clinical trial start-up and execution. The…
Why Does Your CRO’s Assignment Practice for CRAs Matter?
Monitoring the progress of the research represents a fundamental aspect of successful outcomes by ensuring that constraints to success are…
Does Your Monitoring Vendor Hold the Key to Improving the Quality of Your Database?
This article will discuss how involving your specialized CRO early in the database development phase can reduce the risk of…
Busting Myths about the Canadian Regulatory Review Process – An interview with Susanne Picard
In this interview, Susanne Picard, Founder & President of SPharm Inc., answers questions about the Canadian regulatory environment and dispels…